Stock Track | DaVita HealthCare Partners Soars 13.54% in Pre-Market on Strong Earnings and Strategic Home-Care Investment

Stock Track18:39

DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.

The sharp upward movement is driven by the company's better-than-expected fourth-quarter financial results and an optimistic profit forecast for 2026 that exceeded analyst estimates. DaVita reported adjusted earnings per share of $3.40 on revenue of $3.62 billion for Q4 2025, surpassing expectations. Furthermore, the company provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, signaling strong confidence in future performance fueled by steady demand for its kidney dialysis services, higher reimbursement rates, and recovery from prior operational challenges.

Adding to the positive sentiment, DaVita announced a strategic minority investment in home-care provider Elara Caring. The partnership aims to co-develop a kidney-specific home-based care model, which is expected to reduce hospitalizations and lower costs, supporting the company's growth initiatives in personalized patient care.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181757322?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 18:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181757322","market":"us","top_or_hot":-1,"title":"Stock Track | DaVita HealthCare Partners Soars 13.54% in Pre-Market on Strong Earnings and Strategic Home-Care Investment","media":"Stock Track","content":"<p>DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.</p><p>The sharp upward movement is driven by the company's better-than-expected fourth-quarter financial results and an optimistic profit forecast for 2026 that exceeded analyst estimates. DaVita reported adjusted earnings per share of $3.40 on revenue of $3.62 billion for Q4 2025, surpassing expectations. Furthermore, the company provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, signaling strong confidence in future performance fueled by steady demand for its kidney dialysis services, higher reimbursement rates, and recovery from prior operational challenges.</p><p>Adding to the positive sentiment, DaVita announced a strategic minority investment in home-care provider Elara Caring. The partnership aims to co-develop a kidney-specific home-based care model, which is expected to reduce hospitalizations and lower costs, supporting the company's growth initiatives in personalized patient care.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | DaVita HealthCare Partners Soars 13.54% in Pre-Market on Strong Earnings and Strategic Home-Care Investment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | DaVita HealthCare Partners Soars 13.54% in Pre-Market on Strong Earnings and Strategic Home-Care Investment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-03 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.</p><p>The sharp upward movement is driven by the company's better-than-expected fourth-quarter financial results and an optimistic profit forecast for 2026 that exceeded analyst estimates. DaVita reported adjusted earnings per share of $3.40 on revenue of $3.62 billion for Q4 2025, surpassing expectations. Furthermore, the company provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, signaling strong confidence in future performance fueled by steady demand for its kidney dialysis services, higher reimbursement rates, and recovery from prior operational challenges.</p><p>Adding to the positive sentiment, DaVita announced a strategic minority investment in home-care provider Elara Caring. The partnership aims to co-develop a kidney-specific home-based care model, which is expected to reduce hospitalizations and lower costs, supporting the company's growth initiatives in personalized patient care.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1181757322","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181757322","pubTimestamp":1770115172,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.The sharp upward movement is driven by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"股票追踪|DaVita HealthCare Partners盘前飙升13.54%，得益于强劲的盈利和战略性的家庭护理投资","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"DaVita HealthCare Partners Inc. (DVA) experienced a significant pre-market surge of 13.54% on Tuesday, following a substantial after-hours gain the previous day.The sharp upward movement is driven by the company's better-than-expected fourth-quarter financial results and an optimistic profit forecast for 2026 that exceeded analyst estimates. DaVita reported adjusted earnings per share of $3.40 on revenue of $3.62 billion for Q4 2025, surpassing expectations. Furthermore, the company provided 2026 adjusted EPS guidance in the range of $13.60 to $15.00, signaling strong confidence in future performance fueled by steady demand for its kidney dialysis services, higher reimbursement rates, and recovery from prior operational challenges.Adding to the positive sentiment, DaVita announced a strategic minority investment in home-care provider Elara Caring. The partnership aims to co-develop a kidney-specific home-based care model, which is expected to reduce hospitalizations and lower costs, supporting the company's growth initiatives in personalized patient care.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181757322","isCrawlerRequest":true}